Physician

Michael Charles Bounds, M.D.

According to 2025 Medicare claims, Michael Bounds, M.D. (NPI: 1568755825) practices vascular surgery in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is MID ATLANTIC SURGICAL GROUP (NPI: 1215122809; TIN: 52-1101901) and primary practice location at 21804-1667.

Bounds' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 648 traditional Medicare patients, billed 2,146 HCPCS/CPT codes, and received $443,829 in Medicare payments. The top billing code was 93925 (Ultrasound of leg arteries or artery grafts). Part D data shows 302 prescription claims across 124 beneficiaries totaling $45,632 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 27 records totaling $1,860. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $42,085 to $443,829. Similarly, Part D prescription costs have risen steadily, from $2,870 to $45,632. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$254K$508K2018 Medicare payment: $42,085 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $99,097 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $65,406 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $474,230 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $508,356 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $424,117 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $443,829 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018248374$42,085
2019470876$99,097
2020386658$65,406
20217171,831$474,230
20227301,967$508,356
20235731,926$424,117
20246482,146$443,829

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $2,870 (USD; Tot_Drug_Cst)2016 Drug cost: $18,963 (USD; Tot_Drug_Cst)2017 Drug cost: $3,634 (USD; Tot_Drug_Cst)2018 Drug cost: $1,362 (USD; Tot_Drug_Cst)2019 Drug cost: $9,408 (USD; Tot_Drug_Cst)2020 Drug cost: $6,364 (USD; Tot_Drug_Cst)2021 Drug cost: $8,270 (USD; Tot_Drug_Cst)2022 Drug cost: $18,661 (USD; Tot_Drug_Cst)2023 Drug cost: $35,799 (USD; Tot_Drug_Cst)2024 Drug cost: $45,632 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155788$2,870
201664141$18,963
20173999$3,634
2018N/R13$1,362
20192867$9,408
20202757$6,364
202142127$8,270
202268218$18,661
2023107327$35,799
2024124302$45,632

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93925Ultrasound of leg arteries or artery grafts92106$180
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9494$130
93880Ultrasound of both sides of head and neck blood flow116130$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more158193$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more273355$70

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban241,200$21,786
EliquisApixaban161,095$19,240
ClopidogrelClopidogrel Bisulfate14311,912$2,159
Atorvastatin CalciumAtorvastatin Calcium543,540$644
Oxycodone HclOxycodone Hcl1957$79

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$1,860W. L. Gore & Associates, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Charles Bounds, M.D.?

Tedicare shows public-source Medicare data for Michael Charles Bounds, M.D. (NPI 1568755825), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Charles Bounds, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Charles Bounds, M.D.?

Michael Charles Bounds, M.D. is linked to MID ATLANTIC SURGICAL GROUP (billing NPI 1215122809) in the available physician profile data.

Does Michael Charles Bounds, M.D. have Open Payments data?

Michael Charles Bounds, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.